In Pharma Focus Asia newest issue, you can read the interview with our Managing Director Ulla Grove Krogsgaard Thomsen. In the interview, she talks about the role of formal documentation in quality assurance, ensuring the quality of materials and products, the benefits of using cGMP Quats as excipients in topical, nasal and ophthalmic applications and how we as a company ensure that industry standards are met. Ulla Grove Krogsgaard Thomsen also addresses the biggest challenges currently facing the pharmaceutical market.
You can read the entire interview here.